Associated Papers
Novel SNP Combination for Predictive Osteoporotic Diagnosis.
Sopova JV et al.
International Journal of Molecular Sciences, 2025
Whole-Genome Sequencing Reveals a Novel GATA2 Mutation in Lower-Grade Glioma: Bioinformatics Analysis of Functional and Therapeutic Implications.
Handoko et al.
Cancers, 2025
Pharmacogenomics in cardiac therapy: Personalizing treatment for heart health.
Naderi N et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 2025
ADRB2 Polymorphisms (rs1042713 and rs1042714) and Blood Pressure Response to the Cold Pressor Test in Combat Athletes and Non-Athletes.
Sawczuk M et al.
International Journal of Molecular Sciences, 2025
Derivation of hiPSC line (ICADRB2i007-A-3) from an individual with osteoporosis linked to ADRB2: c.46G > A.
Krasnova O et al.
Human Cell, 2025
The pharmacogenomic landscape in the Chinese: An analytics of pharmacogenetic variants in 206,640 individuals.
Wang LY et al.
Innovation (cambridge (mass.)), 2025
Influence of ADRB2 variants on bronchodilator response and asthma control in a mixed population.
Rodrigues PASDS et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia, 2025
Unraveling the Mechanism of Impaired Osteogenic Differentiation in Osteoporosis: Insights from ADRB2 Gene Polymorphism.
Krasnova O et al.
Cells, 2024
The Role of Single Nucleotide Polymorphisms in Beta-2 Adrenergic Receptors in the Severity of Obstructive Sleep Apnea Syndrome in Pediatric Patients.
Ferrari M et al.
Cureus, 2024
Influence of genetic polymorphism on sports talent performance versus non-athletes: a systematic review and meta-analysis.
Ferreira CP et al.
Bmc Sports Science, Medicine & Rehabilitation, 2024
Population-specific putative causal variants shape quantitative traits.
Koyama S et al.
Nature Genetics, 2024
Single nucleotide polymorphism-based biomarker in primary hypertension.
Laxmi et al.
European Journal of Pharmacology, 2024
Genetic Variants of Adrenoceptors.
Ahles A et al.
Handbook of Experimental Pharmacology, 2024
Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome.
Castaño-Amores C et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 2023
Global analysis of suppressor mutations that rescue human genetic defects.
Ünlü B et al.
Genome Medicine, 2023
Integration of genetic fine-mapping and multi-omics data reveals candidate effector genes for hypertension.
van Duijvenboden S et al.
American Journal of Human Genetics, 2023
Functional mutation, splice, distribution, and divergence analysis of impactful genes associated with heart failure and other cardiovascular diseases.
Mhatre I et al.
Scientific Reports, 2023
Impact of Polymorphism in the β2-Receptor Gene on the Metabolic Response to Epinephrine After Repeated Hypoglycemia.
Rokamp KZ et al.
Diabetes, 2023
A Comprehensive Review of the Genetic and Epigenetic Contributions to the Development of Fibromyalgia.
Ovrom EA et al.
Biomedicines, 2023
Impact of Neuroeffector Adrenergic Receptor Polymorphisms on Incident Ventricular Fibrillation During Acute Myocardial Ischemia.
Chevalier P et al.
Journal of the American Heart Association, 2023
The impact of ADRB2 polymorphisms on immune responses and norepinephrine-induced immunosuppression.
Stolk RF et al.
Journal of Leukocyte Biology, 2023
Study of the Association of Single Nucleotide Polymorphisms in Candidate Genes With Sevoflurane.
Zhao S et al.
Journal of Clinical Pharmacology, 2023
Immunogenetics and pharmacogenetics of allergic asthma in Africa.
Mabelane T et al.
Frontiers in Allergy, 2023
Genetic Contribution of the Adrenergic, Cholinergic, and Serotonergic Systems to Leiomyoma Development and Treatment.
Inácio  et al.
International Journal of Molecular and Cellular Medicine, 2023
Genetics of long-distance runners and road cyclists-A systematic review with meta-analysis.
Konopka MJ et al.
Scandinavian Journal of Medicine & Science in Sports, 2022
Pharmacogenetics may explain part of the interindividual variability of dobutamine pharmacodynamics in neonates.
Hallik M et al.
British Journal of Clinical Pharmacology, 2022
Impact of Polymorphism in the β2-Receptor Gene on Metabolic Responses to Repeated Hypoglycemia in Healthy Humans.
Rokamp KZ et al.
The Journal of Clinical Endocrinology and Metabolism, 2022
ADRB2 gene influences responsiveness to physical exercise programs: A longitudinal study applied to overweight or obese Brazilian children and adolescents.
de Souza E Silva S et al.
Gene, 2022
Effect of Beta 2-Adrenergic Receptor Gly16Arg Polymorphism on Taste Preferences in Healthy Young Japanese Adults.
Narita K et al.
Nutrients, 2022
Genomic analysis to screen potential genes and mutations in children with non-syndromic early onset severe obesity: a multicentre study in Turkey.
Akinci A et al.
Molecular Biology Reports, 2022
Genetic polymorphisms in ADRB2 and ADRB1 are associated with differential survival in heart failure patients taking β-blockers.
Guerra LA et al.
The Pharmacogenomics Journal, 2022
Clinical Implication of Genetic Testing in Dilated Cardiomyopathy.
Lee JH et al.
International Journal of Heart Failure, 2022
Outcomes of Genetic Testing-Based Cardiac Rehabilitation Program in Patients with Acute Myocardial Infarction after Percutaneous Coronary Intervention.
Yu X et al.
Cardiology Research and Practice, 2022
Case report: Whole-exome sequencing identifies a novel DES mutation (p. E434K) in a Chinese family with cardiomyopathy and sudden cardiac death.
Liu YX et al.
Frontiers in Cardiovascular Medicine, 2022
Pharmacogenetic polymorphisms affecting bisoprolol response.
Castaño-Amores C et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 2021
Towards Understanding the Genetic Nature of Vasovagal Syncope.
Matveeva N et al.
International Journal of Molecular Sciences, 2021
Asthma prescribing according to Arg16Gly beta-2 genotype: a randomised trial in adolescents.
Ruffles T et al.
The European Respiratory Journal, 2021
Genomic selection signatures in autism spectrum disorder identifies cognitive genomic tradeoff and its relevance in paradoxical phenotypes of deficits versus potentialities.
Prakash A et al.
Scientific Reports, 2021
CRISPR/Cas9-mediated generation and analysis of N terminus polymorphic models of β2AR in isogenic hPSC-derived cardiomyocytes.
Kondrashov A et al.
Molecular Therapy. Methods & Clinical Development, 2021
The role of ADRB2 gene polymorphisms in malignancies.
Wang Y et al.
Molecular Biology Reports, 2021
Influence of ADRB1, ADRB2, and COMT Genetic Polymorphisms on Postoperative Outcomes of Patients Undergoing Cardiac Valve Surgery.
Dai S et al.
Clinical Therapeutics, 2021
Decoding variants in drug-metabolizing enzymes and transporters in solid tumor patients by whole-exome sequencing.
Aboul-Soud MAM et al.
Saudi Journal of Biological Sciences, 2021
Pharmacogenetic factors affecting β-blocker metabolism and response.
Thomas CD et al.
Expert Opinion on Drug Metabolism & Toxicology, 2020
The Identification of Admixture Patterns Could Refine Pharmacogenetic Counseling: Analysis of a Population-Based Sample in Mexico.
Martínez-Magaña JJ et al.
Frontiers in Pharmacology, 2020
Association of β2-adrenergic receptor gene polymorphisms (rs1042713, rs1042714, rs1042711) with asthma risk: a systematic review and updated meta-analysis.
Zhao S et al.
Bmc Pulmonary Medicine, 2019